Enhancing the Capacity of Pediatric Primary Care Providers: A Pilot Trial of Anxiety Action Plan
增强儿科初级保健提供者的能力:焦虑行动计划试点
基本信息
- 批准号:10574022
- 负责人:
- 金额:$ 26.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcademyAcheAddressAdherenceAdultAdvisory CommitteesAgeAmericanAnxietyAnxiety DisordersAsthmaAttention deficit hyperactivity disorderBehavioralChildChildhoodClinical TreatmentCognitive TherapyCommunitiesCost-Benefit AnalysisCosts and BenefitsDevelopmentDiseaseEducational GrantsEffectivenessElementsEvidence based interventionFamilyFeedbackFundingFutureGoalsHealth ProfessionalHealth Services AccessibilityHigh PrevalenceImpairmentInterventionKnowledgeLocationMeasuresMediatorMedicalMental HealthMental Health ServicesMental disordersMethodsModelingNational Institute of Mental HealthNurse PractitionersNursesOffice VisitsParentsPediatricsPhysician AssistantsPrevalencePrimary CareProviderRandomizedRandomized, Controlled TrialsRecommendationReportingResearch PersonnelSchool NursingSeveritiesSpecialistStomachSurgeonTechnologyTestingTherapeuticTrainingUnited States National Institutes of HealthVisitWorkYouthanxiety reductionanxiousbrief interventionchildhood anxietyclinical carecommunity settingdesigndisabilityeconomic costeffectiveness trialevidence baseexcessive anxietyfollow-upimprovedinnovationmedical specialtiesmental health centernovelpediatricianpilot testpilot trialpost interventionpreventive interventionprimary care clinicprimary care providerprimary care settingprimary care visitservice deliveryservice gapservice interventionskillstheoriestreatment as usualvirtualvirtual deliveryvirtual visit
项目摘要
Anxiety disorders in youth are: 1) the most prevalent psychiatric illnesses, 2) associated with severe disability,
and 3) considered gateway disorders--as they predict a broad range of adult psychiatric and functional
problems. Despite the high prevalence and impairment, less than half of anxious youth receive mental health
services and access to evidenced-based interventions lags far behind that of less common psychiatric
illnesses, such as attention deficit hyperactivity disorder. This application addresses this mental health service
gap and responds to NIH’s priorities in PAR-MH-21-131: Pilot Effectiveness Trials for Treatment, Preventive
and Services Interventions (R34) aimed at testing interventions with previous efficacy in community settings
using novel service delivery methods. Specifically, we propose to refine and assess the feasibility of the
Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers
(PCPs; defined here as nurse practitioners, physician assistants, and/or pediatricians) in community pediatric
primary care clinics. Primary care settings are ideal for addressing pediatric anxiety specifically because: 1)
prevalence rates of excessive anxiety are high in primary care (approximately 10-20%), 2) over 90% of anxious
youth report physical complaints (e.g., stomach aches) and are “frequent flyers” in primary care settings, 3)
children with, compared to without, medical conditions treated by PCPs are more likely to have elevated
anxiety, and 4) PCPs are often the first and only health professional children visit. This proposal builds on the
PI’s development and feasibility pilot work with PCPs conducted as part of the NIMH-funded Center for Mental
Health in Pediatric Primary Care and with school nurses as part of a Department of Education grant. The
AxAP, modeled after the Asthma Action Plan familiar to PCPs, is based on the core element of cognitive
behavioral therapy for anxiety (i.e., behavioral exposure), was designed to fit within the short primary care visit
(20-30 minutes), can be delivered virtually, is brief (1-4 sessions), and can be billed for as an office visit.
Uniquely, and in stark contrast to co-location or integrated models, the goal of the AxAP is to enhance the
capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general
and especially in locations with few mental health specialists. The proposal also incorporates several innovative
features including pilot tests of measures to conduct: 1) a cost-benefit analysis of the AxAP and 2) an
examination of theory-based target mechanisms at the child, parent and PCP levels. If results of this study are
positive, findings would support a large effectiveness trial using an intervention that is ready for dissemination
and that could significantly improve clinical care for anxious youth, enhance the capacity of PCPs to identify
and reduce anxiety, and lower personal and economic costs associated with pediatric anxiety.
青少年焦虑症包括:1) 最常见的精神疾病,2) 与严重残疾相关,
3) 考虑了网关障碍——因为它们预测了广泛的成人精神和功能障碍
尽管焦虑症的患病率和损伤率很高,但只有不到一半的焦虑青少年获得了心理健康。
服务和获得循证干预措施的机会远远落后于不太常见的精神病学
患有注意力缺陷多动障碍的人该应用程序解决了这种心理健康服务。
差距并响应 NIH 在 PAR-MH-21-131 中的优先事项:治疗、预防的试点有效性试验
和服务干预措施(R34),旨在测试社区环境中以前的干预措施的有效性
具体来说,我们建议完善和评估该服务的可行性。
焦虑行动计划 (AxAP),由初级保健提供者提供的一项旨在减少儿科焦虑的简短干预措施
(PCP;此处定义为社区儿科执业护士、医师助理和/或儿科医生)
初级保健诊所是解决儿科焦虑的理想场所,具体原因是:1)
初级保健中过度焦虑的患病率很高(约 10-20%),2) 超过 90% 的焦虑症患者
青少年报告身体不适(例如胃痛)并且是初级保健机构的“常旅客”,3)
与未接受 PCP 治疗的儿童相比,患有疾病的儿童更有可能升高
焦虑,以及 4) PCP 通常是儿童第一个也是唯一一个就诊的健康专业人员。
PI 与 PCP 的开发和可行性试点工作是 NIMH 资助的精神中心的一部分
作为教育部拨款的一部分,儿科初级保健和学校护士的健康。
AxAP 仿照 PCP 熟悉的哮喘行动计划,基于认知的核心要素
焦虑的行为疗法(即行为暴露)旨在适应短期初级保健就诊
(20-30 分钟),可以虚拟授课,时间简短(1-4 次会议),并且可以按办公室访问付费。
与托管或集成模型形成鲜明对比的是,AxAP 的独特之处在于增强
PCP 识别和干预焦虑青少年的能力,这将提高总体护理的可及性
特别是在心理健康专家很少的地区,该提案还包含了一些创新内容。
功能包括对以下措施进行试点测试:1) AxAP 的成本效益分析,2)
如果本研究的结果是,则在儿童、家长和 PCP 层面检查基于理论的目标机制。
积极的结果将支持使用可传播的干预措施进行大规模有效性试验
这可以显着改善对焦虑青少年的临床护理,增强 PCP 识别的能力
减少焦虑,并降低与儿科焦虑相关的个人和经济成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Golda Susan Ginsburg其他文献
Golda Susan Ginsburg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Golda Susan Ginsburg', 18)}}的其他基金
2/2-Unified Treatment of Adolescent Emotional Disorders in Community Clinics
2/2-社区诊所青少年情绪障碍统一治疗
- 批准号:
9212696 - 财政年份:2015
- 资助金额:
$ 26.69万 - 项目类别:
Child Anxiety Prevention Study Long term Extension
儿童焦虑预防研究长期延伸
- 批准号:
9242077 - 财政年份:2015
- 资助金额:
$ 26.69万 - 项目类别:
Integrating Biological Markers into Clinical Research
将生物标记物整合到临床研究中
- 批准号:
9020999 - 财政年份:2015
- 资助金额:
$ 26.69万 - 项目类别:
Child Anxiety Prevention Study Long term Extension
儿童焦虑预防研究长期延伸
- 批准号:
8818879 - 财政年份:2015
- 资助金额:
$ 26.69万 - 项目类别:
Child Anxiety Prevention Study Long term Extension
儿童焦虑预防研究长期延伸
- 批准号:
9066817 - 财政年份:2015
- 资助金额:
$ 26.69万 - 项目类别:
Integrating Biological Markers into Clinical Research
将生物标记物整合到临床研究中
- 批准号:
8955452 - 财政年份:2015
- 资助金额:
$ 26.69万 - 项目类别:
Integrating Biological Markers into Clinical Research
将生物标记物整合到临床研究中
- 批准号:
8442480 - 财政年份:2013
- 资助金额:
$ 26.69万 - 项目类别:
相似国自然基金
β-羟基丁酸介导NF-kB p65去乙酰化修饰在经腹功能性磁刺激治疗脊髓损伤后神经病理性疼痛中的机制研究
- 批准号:82302862
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
低强度聚焦超声调控前扣带回皮层抑制中枢敏化缓解慢性神经病理性疼痛的机制研究
- 批准号:82360457
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
IL-17调控M1/M2巨噬细胞极化失衡介导CNP疼痛的机制研究
- 批准号:82370776
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
初级感觉神经元启动皮层重塑在慢性疼痛形成过程中的作用及机制研究
- 批准号:82301409
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脊髓电刺激通过内侧前额叶PV神经元STING磷酸化调控蓝斑核神经环路改善神经病理性疼痛的机制研究
- 批准号:82301407
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
- 批准号:
10739853 - 财政年份:2023
- 资助金额:
$ 26.69万 - 项目类别:
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients
高剂量与标准剂量流感疫苗在儿科实体器官移植受者中的比较
- 批准号:
10621099 - 财政年份:2023
- 资助金额:
$ 26.69万 - 项目类别:
Pathogenesis of myalgia and fatigue after SARS-CoV-2 infection
SARS-CoV-2感染后肌痛和疲劳的发病机制
- 批准号:
10709579 - 财政年份:2022
- 资助金额:
$ 26.69万 - 项目类别:
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
远程神经学与多发性硬化症临床护理标准的临床和经济影响:随机试验
- 批准号:
10583096 - 财政年份:2022
- 资助金额:
$ 26.69万 - 项目类别:
Refined uncharged Bis-Oximes for Rapid CNS Reactivation of OP-Inhibited hAChE.
用于快速 CNS 重新激活 OP 抑制的 hAChE 的精制不带电双肟。
- 批准号:
10407766 - 财政年份:2022
- 资助金额:
$ 26.69万 - 项目类别: